This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Sanofi. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Maria Mendez Perez: Innovating Insulin Conjugates in Frankfurt am Main
Introduction: Maria Mendez Perez is a notable inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of pharmaceuticals, particularly concerning insulin formulations. With her dedication and innovative spirit, Maria aims to improve the lives of individuals relying on insulin therapy.
Latest Patents: Maria holds a patent for her invention titled "Insulin Conjugates." This groundbreaking invention relates to a conjugate that incorporates a sulfonamide and an active pharmaceutical ingredient, specifically an insulin analog featuring at least one mutation from the parent insulin. The patent details mutations at position B16 and position B25 of the insulin analog, where both are substituted with hydrophobic amino acids. Additionally, her invention introduces a specific sulfonamide formula, showcasing her drive to advance pharmaceutical science.
Career Highlights: Currently, Maria is employed by Sanofi, a leading global biopharmaceutical company. Her role at Sanofi allows her to collaborate with top-tier professionals and contribute to the development of innovative therapeutic solutions. Her patent signifies her expertise in biotechnology, reinforcing her status as a prominent figure in the industry.
Collaborations: At Sanofi, Maria collaborates closely with talented colleagues, including Nils Rackelmann and Laurent Bialy. Together, they share a commitment to pioneering breakthroughs in insulin therapies, fostering a collaborative environment that prioritizes innovation and excellence in research.
Conclusion: Maria Mendez Perez exemplifies the essence of innovation in the pharmaceutical industry. Her work on insulin conjugates marks a significant advancement in drug development, underscoring her role as a key inventor in the field. As she continues to thrive in her career at Sanofi, the medical community eagerly anticipates future contributions that will stem from her innovative research endeavors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile